Screener
Baxter International BAX Healthcare Systems & Technologies — Segment operating income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Baxter International’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:50 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028962
| (in millions) | Three Months Ended March 31, 2026 / Medical Products & Therapies | Three Months Ended March 31, 2026 / Healthcare Systems & Technologies | Three Months Ended March 31, 2026 / Pharmaceuticals | Three Months Ended March 31, 2025 / Medical Products & Therapies | Three Months Ended March 31, 2025 / Healthcare Systems & Technologies | Three Months Ended March 31, 2025 / Pharmaceuticals |
|---|---|---|---|---|---|---|
| Net sales | $1,285 | $705 | $621 | $1,262 | $704 | $581 |
| Cost of sales | 781 | 390 | 458 | 694 | 356 | 396 |
| Selling, general and administrative expenses | 290 | 209 | 102 | 286 | 217 | 103 |
| Research and development expenses | 54 | 49 | 22 | 59 | 45 | 26 |
| Other segment items | (26) | (9) | (7) | (21) | (7) | (7) |
| Segment operating income | $186 | $66 | $46 | $244 | $93 | $63 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Baxter International's healthcare systems & technologies — segment operating income?
- Baxter International (BAX) reported healthcare systems & technologies — segment operating income of $66M in Q1 2026.
- How has Baxter International's healthcare systems & technologies — segment operating income changed year-over-year?
- Baxter International's healthcare systems & technologies — segment operating income decreased by 29.0% year-over-year, from $93M to $66M.
- What is the long-term trend for Baxter International's healthcare systems & technologies — segment operating income?
- Over 3 years (2021 to 2025), Baxter International's healthcare systems & technologies — segment operating income has grown at a 94.4% compound annual growth rate (CAGR), from $60M to $441M.
- What does healthcare systems & technologies — segment operating income mean?
- The profit generated by the segment after deducting cost of sales, operating expenses, and R&D from net sales. It serves as the primary measure of the segment's core operational profitability.
Ask your AI about Baxter International's healthcare systems & technologies — segment operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude